시장보고서

상품코드

1571608

영양유전체학 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 제품별, 기법별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Product, By Technique, By End Use, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

영양유전체학 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 영양유전체학 시장 규모는 2024년부터 2030년까지 17.4%의 CAGR을 기록하며 2030년까지 14억 달러에 달할 것으로 예상됩니다.

이러한 성장은 특히 선진국에서 비만과 심혈관질환(CVDs)의 증가에 기인합니다. 영양유전체학은 개인화된 유전자 기반 식단을 제공함으로써 비만 예방에 중요한 역할을 할 수 있습니다. 노인 인구의 증가와 함께 이 제품에 대한 인식이 높아지는 것도 시장 성장을 촉진할 것입니다.

영양유전체학의 비만 및 암 연구 응용 분야는 2023년 시장 리더로 부상했으며, 예측 기간 동안 상당한 CAGR로 확대되어 우위를 유지할 것으로 예상됩니다. 아시아태평양, 라틴아메리카, 중동 등 신흥국 시장도 비만 환자 증가와 노령 인구 증가로 인해 빠르게 성장할 것으로 예상됩니다.

영양유전체학 시장 보고서 하이라이트

영양유전체학 세계 시장 규모는 2023년 4억 4,820만 달러로 2024년부터 2030년까지 연평균 17.4% 성장할 것으로 예상됩니다.
2023년에는 비만 응용 분야가 시장을 주도했으며, 2030년에는 업계 점유율의 38%를 차지할 것으로 추정됩니다.
암 연구는 예측 기간 동안 영양유전체학 응용 분야 중 가장 빠르게 성장하여 CAGR 18.0%를 기록할 것으로 예상됩니다.
북미는 2023년 가장 큰 시장 점유율을 차지했으며, 앞으로도 그 우위를 유지할 것으로 추정됩니다.
아시아태평양 영양유전체학 시장은 당뇨병, 비만, 심장병 등 만성질환의 유병률 증가에 힘입어 18.1%의 가파른 성장세를 보일 것으로 예상됩니다.

영양유전체학 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Nutrigenomix
- The Gene Box
- Metagenics
- Xcode Life
- GX Sciences, LLC(Fagron)
- Cura Integrative Medicine
- dnalife
- Genova Diagnostics(GDX)
- HOLISTIC HEALTH INTERNATIONAL, LLC

ksm 24.10.31

Nutrigenomics Market Growth & Trends:

The global nutrigenomics market size is expected to reach USD 1.4 billion by 2030 registering a CAGR of 17.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth.

Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2023 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population.

Nutrigenomics Market Report Highlights:

The global nutrigenomics market size was valued at USD 448.2 million in 2023 and is projected to grow at a CAGR of 17.4% from 2024 to 2030
Obesity application segment led the market in 2023 and is estimated to account for a 38% of the industry share by 2030
Cancer research is projected to be the fastest-growing application of nutrigenomics over the forecast period, registering a CAGR of 18.0%.
North America accounted for the largest market share in 2023 and is estimated to maintain its dominance over the years to come
Asia Pacific nutrigenomics market is expected to experience the fastest growth of 18.1%, driven by the increasing prevalence of chronic diseases such as diabetes, obesity, and heart disease

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Nutrigenomics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Nutrigenomics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Nutrigenomics Market: Application Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Nutrigenomics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
4.3. Obesity
- 4.3.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cardiovascular Diseases
- 4.4.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Cancer Research
- 4.5.1. Cancer Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
- 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nutrigenomics Market: Product Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Nutrigenomics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
5.3. Reagents & Kits
- 5.3.1. Reagents &Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Services
- 5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nutrigenomics Market: Technique Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Nutrigenomics Market: Technique Movement Analysis, 2023 & 2030 (USD Million)
6.3. Saliva
- 6.3.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Buccal Swab
- 6.4.1. Buccal Swab Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Blood
- 6.5.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Nutrigenomics Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Nutrigenomics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Hospitals & Clinics
- 7.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Others
- 7.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Nutrigenomics Market: Regional Estimates & Trend Analysis

8.1. Nutrigenomics Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
- 8.2.1. North America Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. U.S. Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Canada Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. Mexico
  - 8.2.4.1. Mexico Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
- 8.3.1. Europe Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. UK
  - 8.3.2.1. UK Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Germany
  - 8.3.3.1. Germany Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. France
  - 8.3.4.1. France Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Italy Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Spain Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Denmark Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Sweden Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Norway Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. China
  - 8.4.2.1. China Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Japan
  - 8.4.3.1. Japan Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
  - 8.4.4.1. India Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. South Korea
  - 8.4.5.1. South Korea Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Australia
  - 8.4.6.1. Australia Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
  - 8.4.7.1. Thailand Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
- 8.5.1. Latin America Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Brazil Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Argentina
  - 8.5.3.1. Argentina Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. South Africa Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. Saudi Arabia Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. UAE
  - 8.6.4.1. UAE Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
  - 8.6.5.1. Kuwait Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- 9.4.1. Nutrigenomix
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/Strategic Initiatives
- 9.4.2. The Gene Box
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/Strategic Initiatives
- 9.4.3. Metagenics
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/Strategic Initiatives
- 9.4.4. Xcode Life
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/Strategic Initiatives
- 9.4.5. GX Sciences, LLC (Fagron)
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/Strategic Initiatives
- 9.4.6. Cura Integrative Medicine
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/Strategic Initiatives
- 9.4.7. dnalife
  - 9.4.7.1. Participant's Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Recent Developments/Strategic Initiatives
- 9.4.8. Genova Diagnostics (GDX)
  - 9.4.8.1. Participant's Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Recent Developments/Strategic Initiatives
- 9.4.9. HOLISTIC HEALTH INTERNATIONAL, LLC
  - 9.4.9.1. Participant's Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Recent Developments/Strategic Initiatives

영양유전체학 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 제품별, 기법별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Product, By Technique, By End Use, By Region, And Segment Forecasts, 2024 - 2030

영양유전체학 시장 성장과 동향:

영양유전체학 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 영양유전체학 시장 변수, 동향, 범위

제4장 영양유전체학 시장 : 용도 추정·동향 분석

제5장 영양유전체학 시장 : 제품 추정·동향 분석

제6장 영양유전체학 시장 : 기법 추정·동향 분석

제7장 영양유전체학 시장 : 최종 용도 추정·동향 분석

제8장 영양유전체학 시장 : 지역 추정·동향 분석